BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16954232)

  • 1. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A; Wutzler P
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.
    Maple PA; Haedicke J; Quinlivan M; Steinberg SP; Gershon AA; Brown KE; Breuer J
    Epidemiol Infect; 2016 Aug; 144(11):2345-53. PubMed ID: 27018820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Diagnostic Performance of Three Indirect Enzyme-Linked Immunosorbent Assays for the Detection of IgG Antibodies to Ebola Virus in Human Sera.
    Paweska JT; Moolla N; Storm N; Msimang V; Conteh O; Weyer J; Vuren PJV
    Viruses; 2019 Jul; 11(8):. PubMed ID: 31344850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of VZV.
    Wang A; Liu N; Zhao J; Niu Y; Chen Y; Zhou J; Liu E; Zhang G
    J Virol Methods; 2024 Feb; 324():114874. PubMed ID: 38154579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of intrathecal IgG antibody for varicella and measles diagnosis by evaluation and comparison of a commercial IgG chemiluminescent immunoassay with two ELISAs.
    Garcia R; Jiménez-Valera M; Ruiz-Buck D; Sanchez C; Rojas A; Schütz MH; Rojas J; Hunfeld KP
    Eur J Clin Microbiol Infect Dis; 2024 Apr; ():. PubMed ID: 38613705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ELISA for detection of antibodies against porcine epidemic diarrhoea virus (PEDV) based on the specific solubility of the viral surface glycoprotein.
    Knuchel M; Ackermann M; Müller HK; Kihm U
    Vet Microbiol; 1992 Sep; 32(2):117-34. PubMed ID: 1441196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.
    Sauerbrei A; Schäfler A; Hofmann J; Schacke M; Gruhn B; Wutzler P
    Clin Vaccine Immunol; 2012 Aug; 19(8):1261-8. PubMed ID: 22718131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella.
    Kim YH; Hwang JY; Shim HM; Lee E; Park S; Park H
    Yonsei Med J; 2014 Mar; 55(2):459-66. PubMed ID: 24532518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
    Sauerbrei A; Wutzler P
    Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens.
    Schmidt NJ; Gallo D; Devlin V; Woodie JD; Emmons RW
    J Clin Microbiol; 1980 Nov; 12(5):651-5. PubMed ID: 6268653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.
    Williams V; Gershon A; Brunell PA
    J Infect Dis; 1974 Dec; 130(6):669-72. PubMed ID: 4372275
    [No Abstract]   [Full Text] [Related]  

  • 12. Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions.
    Lee C; Kim M; Chun J; Kim S; Yoon D; Lee H; Bang H; Lee HJ; Park H; Kim YB
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of varicella-zoster virus as measured by fluorescent antibody to membrane antigen assay and glycoprotein enzyme-linked immunosorbent assay more than 10 years after initiation of a universal vaccination program: An observational study.
    Ji HS; Kang KR; Kang HM; Choi UY; Lee SY; Kang JH
    Medicine (Baltimore); 2024 Jan; 103(3):e36931. PubMed ID: 38241578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study.
    Choi UY; Kim KH; Cho HK; Kim DH; Ma SH; Choi YY; Kim CS; Capeding MR; Kobashi IAR; Kim H; Ryu JH; Lee SJ; Park HK; Kim JH
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Methods for the Detection of Antibodies of Varicella-Zoster Virus: A Review.
    Pan D; Wang W; Cheng T
    Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an Indirect ELISA Kit for Rapid Detection of Varicella-Zoster Virus Antibody by Glycoprotein E.
    Niu Y; Wang A; Zhou J; Liu H; Chen Y; Ding P; Qi Y; Liang C; Zhu X; Zhang G
    Front Microbiol; 2022; 13():897752. PubMed ID: 35572642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella-Zoster Diagnosis.
    Kombe Kombe AJ; Xie J; Zahid A; Ma H; Xu G; Deng Y; Nsole Biteghe FA; Mohammed A; Dan Z; Yang Y; Feng C; Zeng W; Chang R; Zhu K; Zhang S; Jin T
    Pathogens; 2022 Jan; 11(1):. PubMed ID: 35056014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of rubella serology while on the brink of elimination: evaluation of national data, Belgium, 2017.
    Colman S; Vernelen K; China B; Van den Bossche D; Cornelissen L; Delforge ML; Reynders M; Berth M; Depypere M; Van Gasse N; Vijgen S; Van Acker J; Boel A; Padalko E
    Euro Surveill; 2021 May; 26(20):. PubMed ID: 34018485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan.
    Yasui Y; Mitsui T; Arima F; Uchida K; Inokuchi M; Tokumura M; Nakayama T
    Hum Vaccin Immunother; 2021 Aug; 17(8):2494-2500. PubMed ID: 33650932
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.